bpc-157 evidence human studies safety The Hidden Risks of BPC‑157: What Patients Need to Know About Contamination and The Real BPC-157 Story: 544
Description
To be included, people with MS were required to be 55 years or older, have a disease duration of at least 15 years, and have a minimum of 3 years between their baseline visit and most recent follow-up visit
L., Mercurio, F., Manning, A
The effectiveness of the individual CTP maps (MTT, CBF, TTP, and CBV) in identifying the ischemic area were evaluated
This strategic timing maximizes the peptide's utility
